You just read:

m8 Pharmaceuticals and Gennisium Pharma announce an exclusive License and Distribution Agreement of an orphan hybrid drug for the treatment and prevention of apnea of premature newborns in Mexico and Brazil

News provided by

m8

Apr 28, 2020, 09:00 ET